RPSA and cancer: Additionally targeting telomerase activity by down regulating LRP/LR could potentially be an alternative target for cancer therapy as high telomerase expression in breast cancer has been associated with increased death risk, disease recurrence and plausible (possible) resistance to chemotherapy [42, 43].